Metastatic prostate cancer comes in two forms, which could guide treatment

Are too many Phase III cancer clinical trials set up to fail?

Global cancer risk from burning organic matter comes from unregulated chemicals

Scientists identify new therapeutic target in ovarian cancer subtype with poor prognosis